204 related articles for article (PubMed ID: 23525330)
1. State-dependent etomidate occupancy of its allosteric agonist sites measured in a cysteine-substituted GABAA receptor.
Stewart DS; Hotta M; Desai R; Forman SA
Mol Pharmacol; 2013 Jun; 83(6):1200-8. PubMed ID: 23525330
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan mutations at azi-etomidate photo-incorporation sites on alpha1 or beta2 subunits enhance GABAA receptor gating and reduce etomidate modulation.
Stewart D; Desai R; Cheng Q; Liu A; Forman SA
Mol Pharmacol; 2008 Dec; 74(6):1687-95. PubMed ID: 18805938
[TBL] [Abstract][Full Text] [Related]
3. Etomidate produces similar allosteric modulation in α1β3δ and α1β3γ2L GABA(A) receptors.
Feng HJ; Jounaidi Y; Haburcak M; Yang X; Forman SA
Br J Pharmacol; 2014 Feb; 171(3):789-98. PubMed ID: 24199598
[TBL] [Abstract][Full Text] [Related]
4. Gating allosterism at a single class of etomidate sites on alpha1beta2gamma2L GABA A receptors accounts for both direct activation and agonist modulation.
Rüsch D; Zhong H; Forman SA
J Biol Chem; 2004 May; 279(20):20982-92. PubMed ID: 15016806
[TBL] [Abstract][Full Text] [Related]
5. Gamma-amino butyric acid type A receptor mutations at beta2N265 alter etomidate efficacy while preserving basal and agonist-dependent activity.
Desai R; Ruesch D; Forman SA
Anesthesiology; 2009 Oct; 111(4):774-84. PubMed ID: 19741491
[TBL] [Abstract][Full Text] [Related]
6. An allosteric coagonist model for propofol effects on α1β2γ2L γ-aminobutyric acid type A receptors.
Ruesch D; Neumann E; Wulf H; Forman SA
Anesthesiology; 2012 Jan; 116(1):47-55. PubMed ID: 22104494
[TBL] [Abstract][Full Text] [Related]
7. Cysteine substitutions define etomidate binding and gating linkages in the α-M1 domain of γ-aminobutyric acid type A (GABAA) receptors.
Stewart DS; Hotta M; Li GD; Desai R; Chiara DC; Olsen RW; Forman SA
J Biol Chem; 2013 Oct; 288(42):30373-30386. PubMed ID: 24009076
[TBL] [Abstract][Full Text] [Related]
8. Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant
Szabo A; Nourmahnad A; Halpin E; Forman SA
Mol Pharmacol; 2019 Apr; 95(4):408-417. PubMed ID: 30696720
[TBL] [Abstract][Full Text] [Related]
9. Anesthetic sites and allosteric mechanisms of action on Cys-loop ligand-gated ion channels.
Forman SA; Miller KW
Can J Anaesth; 2011 Feb; 58(2):191-205. PubMed ID: 21213095
[TBL] [Abstract][Full Text] [Related]
10. Substituted Cysteine Modification and Protection with
Fantasia RJ; Nourmahnad A; Halpin E; Forman SA
Mol Pharmacol; 2021 Jun; 99(6):426-434. PubMed ID: 33766924
[TBL] [Abstract][Full Text] [Related]
11. Mutations at beta N265 in γ-aminobutyric acid type A receptors alter both binding affinity and efficacy of potent anesthetics.
Stewart DS; Pierce DW; Hotta M; Stern AT; Forman SA
PLoS One; 2014; 9(10):e111470. PubMed ID: 25347186
[TBL] [Abstract][Full Text] [Related]
12. Tryptophan and Cysteine Mutations in M1 Helices of α1β3γ2L γ-Aminobutyric Acid Type A Receptors Indicate Distinct Intersubunit Sites for Four Intravenous Anesthetics and One Orphan Site.
Nourmahnad A; Stern AT; Hotta M; Stewart DS; Ziemba AM; Szabo A; Forman SA
Anesthesiology; 2016 Dec; 125(6):1144-1158. PubMed ID: 27753644
[TBL] [Abstract][Full Text] [Related]
13. Classic benzodiazepines modulate the open-close equilibrium in alpha1beta2gamma2L gamma-aminobutyric acid type A receptors.
Rüsch D; Forman SA
Anesthesiology; 2005 Apr; 102(4):783-92. PubMed ID: 15791108
[TBL] [Abstract][Full Text] [Related]
14. p-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels.
Husain SS; Stewart D; Desai R; Hamouda AK; Li SG; Kelly E; Dostalova Z; Zhou X; Cotten JF; Raines DE; Olsen RW; Cohen JB; Forman SA; Miller KW
J Med Chem; 2010 Sep; 53(17):6432-44. PubMed ID: 20704351
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of trifluoromethylaryl diazirine and benzophenone derivatives of etomidate that are potent general anesthetics and effective photolabels for probing sites on ligand-gated ion channels.
Husain SS; Nirthanan S; Ruesch D; Solt K; Cheng Q; Li GD; Arevalo E; Olsen RW; Raines DE; Forman SA; Cohen JB; Miller KW
J Med Chem; 2006 Aug; 49(16):4818-25. PubMed ID: 16884293
[TBL] [Abstract][Full Text] [Related]
16. Substituted Cysteine Modification and Protection with n-Alkyl-MTS Reagents Quantifies Steric Changes Induced by a Mutation in Anesthetic Binding Sites on GABA Type A Receptors.
Bhave K; Forman SA
Mol Pharmacol; 2023 Dec; 104(6):266-274. PubMed ID: 37586749
[TBL] [Abstract][Full Text] [Related]
17. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study.
Pistis M; Belelli D; Peters JA; Lambert JJ
Br J Pharmacol; 1997 Dec; 122(8):1707-19. PubMed ID: 9422818
[TBL] [Abstract][Full Text] [Related]
18. Combining Mutations and Electrophysiology to Map Anesthetic Sites on Ligand-Gated Ion Channels.
Forman SA
Methods Enzymol; 2018; 602():369-389. PubMed ID: 29588039
[TBL] [Abstract][Full Text] [Related]
19. Two etomidate sites in α1β2γ2 γ-aminobutyric acid type A receptors contribute equally and noncooperatively to modulation of channel gating.
Guitchounts G; Stewart DS; Forman SA
Anesthesiology; 2012 Jun; 116(6):1235-44. PubMed ID: 22531336
[TBL] [Abstract][Full Text] [Related]
20. Monod-Wyman-Changeux allosteric mechanisms of action and the pharmacology of etomidate.
Forman SA
Curr Opin Anaesthesiol; 2012 Aug; 25(4):411-8. PubMed ID: 22614249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
